Combining Transarterial Chemoembolisation With Reduced Deubiquitinase Activity Reduces Hepatocellular Carcinoma Progression. [PDF]
Tao Y, Yu W, Yang W, Wu Q, Li J.
europepmc +1 more source
Correction: USP30-mediated Deubiquitination of Hexokinase 2 controls the metabolic fate of glucose and tumor progression. [PDF]
Haowei Z +10 more
europepmc +1 more source
Emerging regulatory model of Ubiquitin-Specific Proteases 14 in cancer: from canonical oncogenesis to TME modulation, therapeutic resistance, and non-canonical activities. [PDF]
Wang R +9 more
europepmc +1 more source
VCPIP1 drives diabetic cardiomyopathy by deubiquitinating AMPKγ1 and preventing AMPKα-γ subunit assembly in cardiomyocytes. [PDF]
Han X +13 more
europepmc +1 more source
TTC26 scaffolds MINDY3-mediated RACK1 deubiquitination to drive osteoclastogenesis and pathological bone resorption. [PDF]
Gao Y +9 more
europepmc +1 more source
USP5 in cancer: a therapeutic window into metabolism and drug resistance. [PDF]
Li H, Wang H, Hu T.
europepmc +1 more source
USP5 promotes glycolysis in cervical cancer by stabilizing FOXM1. [PDF]
Su L, Chen R, He T, Su X, Wu C, Wei X.
europepmc +1 more source
Stabilizing hepatic fatty acid oxidation: Editorial on “USP29 alleviates the progression of MASLD by stabilizing ACSL5 through K48 deubiquitination” [PDF]
Myeung Gi Choi +2 more
doaj +1 more source
USP44 Stabilizes MAOB via Deubiquitination to Inhibit Cisplatin Resistance in Lung Adenocarcinoma. [PDF]
Liang Z, Zhang H, Jiang J, Li C, Yuan F.
europepmc +1 more source
Corrigendum: Roles of ubiquitin-specific proteases in inflammatory diseases
Rui Chen +18 more
doaj +1 more source

